Clinical trial
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 21, 2024
- Completion date
- December 31, 2027
- Enrollment
- 264 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.